Skip to main content

Table 2 Frequency and distribution of TILs and of biomarkers evaluated in the tumor cells or in the tumor stroma

From: A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma

Variable

Na

Mean

cells/mm2

Standard deviation

% (Mean)

CD8

76

1513.53

1353.50

 

FOXP3

76

26.37

42.87

 

CD20

76

530.54

1093.47

 

CD4

76

1288.91

1354.23

 

CD163

76

2001,41

1630.75

 

CD68

76

2853.62

2247.43

 

PTEN

76

119.58

48.47

 

pSTAT1

76

119.76

197.67

 

PD1

73

252.59

365.51

 

PD-L1 Tumor

62

  

4.53

PD-L1 Estroma

48

  

12.17

Percentage of TIL

71

  

28.34

  1. aNumber of cases evaluable for the referred parameter